Clinical Observation Of Jingmaitong No.1 For Lower Deep Venous Thrombosis

[Objective]:In this paper, we observed the improving extent of symptoms, signs, blood viscosity and D-dime of deep vein thrombosis patients, in order to judge the clinical efficacy and provide a reliable method for LDVT[Methods]:The subjects were randomly divided into 90 cases of basic treatment group, treatment group and control group,30 cases. Basic treatment group, only to basic treatment, the treatment group received basic treatment and JingMaiTongNO.1 for oral,the control group were given basic treatment and aspirin enteric-coated tablets for oral, three groups of patients were treated for 14 days. Data collection, and statistical analysis of the results.[Results]:1. Treatment efficiency of the treatment group and the control group, the treatment group compared to the base, were statistically significant (P <0.05).2. After the treatment of lower extremity contralateral and ipsilateral circumference difference was reduced, the treatment group difference in circumference (the patella 15cm,10cm tibial tuberosity below) compared to all other groups was statistically significant (P<0.05), the control group and basic treatment group, no statistically significant (P> 0.05), similar to the two groups.3. T After treatment, the whole blood viscosity, D-dimer indicators have declined, the treatment group compared with the other two groups were statistically significant (P<0.05).[Conclusions]:1.Jingmaitong No.1 can effectively improve the patient’s symptoms and signs for (qizhixueyuxing) lower deep venous thrombosis in acute stage.2Jingmaitong No.1 can reduce the blood viscosity, D-dimer content of (qizhixueyuxing) lower deep venous thrombosis in acute stage.